Biological
Pediarix clinical trials
- studies test it
- 9
- open now
- 1
- in phase 3
- 8
- first study started
- 2003
Keep track of what changes. Save the pediarix studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2010 | 1 |
| 2017 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Hiberix (2) · Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (2) · Haemophilus Vaccines (2) · Meningococcal Vaccines (2) · Heptavalent Pneumococcal Conjugate Vaccine (2) · Diphtheria-Tetanus-acellular Pertussis Vaccines (2) · Vaccines (2) · 13-valent pneumococcal vaccine (1)
Studies
Open first, then newest update. How each study uses pediarix is read from its arms, and is right about nine times in ten.
Testing it · 9
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesRecruitingPhase 3PfizerNCT07160244Written as Pediarix
- This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized VaccineCompletedPhase 3GlaxoSmithKlineNCT03207750Written as Pediarix
- Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same VaccinesCompletedPhase 3GlaxoSmithKlineNCT00463437Written as Infanrix penta
- Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm InfantsCompletedPhase 3GlaxoSmithKlineNCT00586612Written as Infanrix™ penta
- 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of AgeCompletedPhase 2GlaxoSmithKlineNCT00129116Written as Infanrix penta ®
- Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccineCompletedPhase 3GlaxoSmithKlineNCT00289783Written as Pediarix
- Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT01000974Written as Pediarix™
- Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenCCompletedPhase 3GlaxoSmithKlineNCT00322335Written as Infanrix™ penta
- Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC VaccineCompletedPhase 3GlaxoSmithKlineNCT00327184Written as Infanrix Penta
Given in every arm · 6 — pediarix is usual care beside what is tested
- Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT03621670Written as Pediarix
- Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014CompletedPhase 3GlaxoSmithKlineNCT00614614Written as Pediarix®
- Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of AgeCompletedPhase 3GlaxoSmithKlineNCT01978093Written as Pediarix®
- Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) VaccineCompletedPhase 2GlaxoSmithKlineNCT00127855Written as Infanrix® Penta
- Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal VaccineCompletedPhase 2GlaxoSmithKlineNCT00129129Written as Pediarix
- Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesCompletedPhase 2GlaxoSmithKlineNCT00134719Written as Infanrix® Penta
As the comparator · 2 — what is tested is compared with pediarix
- Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT02096263Written as Pediarix
- Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old ChildrenCompletedPhase 4GlaxoSmithKlineNCT00611559Written as Infanrix™ penta